Survey finds limited public awareness of CKM syndrome, which is tied to risk factors common in U.S. adults

Only 12% of U.S. adults surveyed said they had heard of cardiovascular-kidney-metabolic (CKM) syndrome, even though nearly 90% have at least one related risk factor, according to a Harris Poll conducted for the American Heart Association. After the term was explained, majorities said it was important to learn more and wanted information on diagnosis and treatment.

The American Heart Association says a large majority of U.S. adults remain unfamiliar with cardiovascular-kidney-metabolic (CKM) syndrome, a recently defined condition that links cardiovascular disease, kidney disease, Type 2 diabetes and obesity into a single clinical framework.

The Association reported that The Harris Poll conducted an online survey of 4,007 U.S. adults ages 18 and older from Aug. 6 to Aug. 22, 2025. In that survey, 12% of respondents said they had heard of “CKM health” or CKM syndrome.

The Heart Association said nearly 90% of U.S. adults have at least one risk factor linked to CKM syndrome, including high blood pressure, abnormal cholesterol, high blood glucose, excess weight and reduced kidney function. It said the overlap of these risk factors increases the risk of heart attack, stroke and heart failure more than any one factor alone.

After respondents were given an explanation of CKM health, 79% agreed it was important to understand more, and 72% said they were interested in learning more. The Association said respondents were most interested in how CKM syndrome is treated (72%) and diagnosed (71%).

The survey also suggested widespread misconceptions about how related conditions should be addressed. The Heart Association reported that 68% of respondents incorrectly believed it is best to manage individual conditions one at a time or were unsure of the best approach, and 42% believed a healthy heart would not likely be damaged by other organ systems or were uncertain.

“We want people to know that it’s really common to have heart, kidney and metabolic risk factors at the same time. It is reassuring that once the CKM connection was defined nearly three-quarters of those responding understood that it was important and wanted to learn more,” Eduardo Sanchez, M.D., FAHA, the American Heart Association’s chief medical officer for prevention, said in the release.

The Association described CKM health as reflecting how the heart, kidneys and metabolic system work together, and said that when one system functions poorly it can worsen the others over time. It also said that for many people, CKM syndrome can be reversible with changes in eating habits, physical activity and appropriate medical treatment.

To expand public and clinical understanding, the Heart Association said its CKM Health Initiative is providing educational tools and an online resource hub, and that it is working with healthcare teams nationwide to improve collaboration among professionals who care for patients with multiple chronic conditions. The Association said it plans to release its first clinical guidelines focused on CKM syndrome in early 2026.

“The heart, kidney and metabolic systems are connected and, as such, should be treated in a coordinated way,” Sanchez said.

相关文章

Global map and diverse people illustrating the rising prevalence of chronic kidney disease worldwide, with medical elements highlighting the need for early detection.
AI 生成的图像

Chronic kidney disease now affects 788 million people worldwide, study finds

由 AI 报道 AI 生成的图像 事实核查

A Lancet analysis estimates that nearly 800 million adults were living with chronic kidney disease in 2023—up from 378 million in 1990—with the illness now ranking ninth among global causes of death. Researchers urge earlier detection and wider access to proven treatments.

Animals across pets, livestock, wildlife and aquaculture are increasingly affected by chronic illnesses long associated with people. A Risk Analysis paper led by the Agricultural University of Athens outlines an integrated model to monitor and manage these conditions across species.

由 AI 报道 事实核查

A large Mayo Clinic study reports that current guidelines fail to detect nearly 90% of people with familial hypercholesterolemia, a common inherited cause of dangerously high cholesterol and early heart disease. Researchers analyzed exome data from more than 84,000 participants and found that most would not have been selected for standard genetic testing. Expanding routine DNA screening, they say, could help identify at-risk individuals earlier and prevent severe cardiovascular outcomes.

Men’s risk of developing cardiovascular disease begins rising faster than women’s starting in the mid-30s, according to an analysis of the long-running CARDIA cohort. Researchers found men reached a 5% cumulative incidence of cardiovascular disease about seven years earlier than women, with coronary heart disease driving most of the gap; traditional risk factors explained only part of the difference.

由 AI 报道 事实核查

Researchers at McMaster University and the Population Health Research Institute report that simple retinal scans, combined with genetic and blood data, may offer a non-invasive window into cardiovascular health and biological aging. An analysis of more than 74,000 people linked simpler eye-vessel patterns to higher heart-disease risk and faster aging. The study, published October 24, 2025, in Science Advances, points to potential early-detection tools that remain under investigation.

A large UK study indicates that statins lower death and heart event risks for adults with type 2 diabetes, regardless of their predicted cardiovascular risk. Benefits appeared even among low-risk individuals, questioning current prescribing guidelines. Side effects remained minimal.

由 AI 报道 事实核查

Researchers at the University of Colorado Anschutz report that alcohol activates a metabolic pathway that generates fructose, which in turn fuels drinking behavior and liver injury in mice. The enzyme ketohexokinase (KHK) drives this process; inhibiting KHK reduced alcohol consumption and protected against liver damage in animal models.

 

 

 

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝